Julia Ketzer
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Evaluation of the Effect of Photodynamic Therapy on CAM-Grown Sarcomas.
Journal: Bioengineering (Basel, Switzerland)
Published: January 20, 2023
Plasma Sequencing for Patients with GIST-Limitations and Opportunities in an Academic Setting.
Journal: Cancers
Published: September 28, 2022
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design Approach.
Journal: Journal of medicinal chemistry
Published: September 15, 2020
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S.
Journal: Chemical science
Published: July 12, 2019
Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.
Journal: British journal of cancer
Published: May 25, 2019
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors - TORC1/2 Inhibition as Salvage Strategy.
Journal: Molecular cancer therapeutics
Published: October 26, 2018
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.
Journal: British journal of cancer
Published: July 17, 2018
Inhibitors to Overcome Secondary Mutations in the Stem Cell Factor Receptor KIT.
Journal: Journal of medicinal chemistry
Published: October 10, 2017
Indazole-Based Covalent Inhibitors To Target Drug-Resistant Epidermal Growth Factor Receptor.
Journal: Journal of medicinal chemistry
Published: February 23, 2017
Insight into the Inhibition of Drug-Resistant Mutants of the Receptor Tyrosine Kinase EGFR.
Journal: Angewandte Chemie (International ed. in English)
Published: June 03, 2016
Covalent-Allosteric Kinase Inhibitors.
Journal: Angewandte Chemie (International ed. in English)
Published: March 06, 2015
Last Updated: 09/26/2026